Serum isocitrate dehydrogenase activity in Reye's syndrome
dc.contributor.author | Deshmukh, Devendra R. | en_US |
dc.contributor.author | Shope, Thomas C. | en_US |
dc.contributor.author | Sarnaik, Ashok P. | en_US |
dc.date.accessioned | 2006-04-07T19:55:05Z | |
dc.date.available | 2006-04-07T19:55:05Z | |
dc.date.issued | 1987-04 | en_US |
dc.identifier.citation | Deshmukh, Devendra R., Shope, Thomas C., Sarnaik, Ashok P. (1987/04)."Serum isocitrate dehydrogenase activity in Reye's syndrome." Biochemical Medicine and Metabolic Biology 37(2): 255-257. <http://hdl.handle.net/2027.42/26752> | en_US |
dc.identifier.uri | http://www.sciencedirect.com/science/article/B6WBN-4C4NVHM-7V/2/ffc3c01cc30bd15dff42c4e56042d376 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/26752 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=3593596&dopt=citation | en_US |
dc.description.abstract | Serum levels of isocitrate dehydrogenase was determined in 12 Reye's syndrome patients and the enzyme levels were compared with serum ornithine carbamyl phosphate, glutamic oxaloacetic transaminase (aspartate aminotransferase), ammonia, and the stages of the disorder. Isocitrate dehydrogenase was elevated in 8 of the 12 patients and there was no direct correlation between elevated serum isocitrate dehydrogenase level and other clinical parameters. | en_US |
dc.format.extent | 182299 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | Elsevier | en_US |
dc.title | Serum isocitrate dehydrogenase activity in Reye's syndrome | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Public Health | en_US |
dc.subject.hlbsecondlevel | Chemistry | en_US |
dc.subject.hlbsecondlevel | Chemical Engineering | en_US |
dc.subject.hlbsecondlevel | Biological Chemistry | en_US |
dc.subject.hlbtoplevel | Engineering | en_US |
dc.subject.hlbtoplevel | Science | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Pediatrics, University of Michigan, Ann Arbor, Michigan 48109, USA | en_US |
dc.contributor.affiliationum | Department of Pediatrics, University of Michigan, Ann Arbor, Michigan 48109, USA | en_US |
dc.contributor.affiliationother | Children's Hospital of Michigan, Detroit, Michigan 48201, USA | en_US |
dc.identifier.pmid | 3593596 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/26752/1/0000304.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1016/0885-4505(87)90034-X | en_US |
dc.identifier.source | Biochemical Medicine and Metabolic Biology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.